The future of open source drug discovery in cancer looks promising, with increasing recognition of its potential to drive innovation and collaboration. Advances in artificial intelligence and machine learning are expected to further enhance data analysis and drug discovery processes. Additionally, global initiatives and partnerships will likely play a crucial role in overcoming current challenges and realizing the full potential of OSDD in cancer research.
